Regeneron Pharmaceuticals (NASDAQ:REGN) released its Q4 earnings on Friday, January 30, 2026 at 06:30 AM.

Here's what's important from the earnings announcement.

Earnings

Regeneron Pharmaceuticals beat estimated earnings by 18.0%, reporting an EPS of $11.44 versus an estimate of $9.69.

Revenue was up $95.00 million from the same period last year.

Earnings History Overview

During the previous quarter, the company beat on EPS by $2.99, leading to a 0.0% increase share price change the next day.

Here's a look at Regeneron Pharmaceuticals's past performance:

To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.